We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · August 17, 2020

Newer Second-Line Glucose-Lowering Drugs vs Thiazolidinediones and Cirrhosis Risk in T2D

Journal of Diabetes and Its Complications


Additional Info

Journal of Diabetes and Its Complications
Newer Second-Line Glucose-Lowering Drugs Versus Thiazolidinediones on Cirrhosis Risk Among Older US Adult Patients With Type 2 Diabetes
J Diabetes Complicat 2020 Aug 05;[EPub Ahead of Print], JY Yang, AM Moon, H Kim, V Pate, AS Barritt IV, MJ Crowley, JB Busee T Stürmer, A-S Alexopoulos

Further Reading